// App-Quantinova.ai

4369 : Genome-wide copy number dependency analysis identifies partial copy loss of SF3B1 as a novel cancer vulnerability

Researchers

Presenter

  • Brenton R. Paolella

Principal Investigators

  • Laura M. Urbanski

  • John A. Alberta

  • Travis I. Zack

  • Pratiti Bandopadhayay

  • Caitlin A. Nichols

  • Pankaj K. Agarwalla

  • Meredith S. Brown

  • Rebecca Lamothe

  • Yong Yu

  • Peter S. Choi

  • Esther A. Obeng

  • Dirk Heckl

  • Benjamin L. Ebert

  • Guo Wei

  • Belinda Wang

  • William C. Hahn

  • Francisca Vazquez

  • Barbara A. Weir

  • Charles D. Stiles

  • Robin Reed

  • Rameen Beroukhim

Medical Centers

  • Dana-Farber Cancer Institute, Boston, MA

  • Massachusetts General Hospital, Boston, MA

  • Harvard Medical School, Boston, MA

  • Broad Institute of MIT and Harvard, Cambridge, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Splicing Factor 3b Subunit 1

Drug/Treatment

  • Minocycline

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A